Attention to acute cerebrovascular disease in Guipúzcoa: description of the results of a reference hospital in a centralized care model

Fernández‐Eulate, Gorka; Arocena, P.; Muñoz-Lopetegi, A.; Rodríguez‐Antigüedad, Jon; Campo‐Caballero, David; Equiza, Jon; Andrés, N.; Arce, Ana de; González, Fernando; Díez, Noemí; Basterrechea, J.; Suquia, E.; Riva, Patricia de la; Martínez-Zabaleta, Maite

doi:10.1016/j.nrleng.2019.03.022

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two indicators related to equity of access in terms of access relative to geographical context or fair and equal access. Five indicators were grouped under effectiveness to highlight resource optimisation and referred to rates of hospital use or proportion of patients hospitalised in a care unit and included the second indicator with the highest frequency of occurrence (15) that is the proportion of hospitalised patients treated in a stroke unit 15 16 19 32 33 35–44. There were no organisational indicators in relation to viability to assess the protocols established to monitor patient care or training offered or any other element implemented to ensure sustainability of good practice.…”

Section: Resultsmentioning

confidence: 99%

Clinical and organisational quality indicators for the optimal management of acute ischaemic stroke in the era of thrombectomy: a scoping review and expert consensus study

Bélanger,

Beaudet,

Lapointe

et al. 2024

BMJ Open

View full text Add to dashboard Cite

ObjectiveThe purpose of this study is to identify clinical and organisational quality indicators conducive to the optimal interdisciplinary management of acute-phase ischaemic stroke.MethodA scoping review based on the six-step methodological framework of Arksey and O’Malley (2005) was conducted including a Delphi process with an experts committee.Data sourcesMEDLINE, CINAHL, Academic search complete, Cochrane Library databases, in addition to Google Scholar and Google were searched through January 2015 to February 2023.Eligibility criteriaFrench and English references, dealing with clinical and organisational indicators for the management and optimal care of adults with acute ischaemic stroke.Data extraction and synthesisAfter duplicate removal, all publications were checked for title and abstract. The full text of articles meeting the inclusion criteria was reviewed. Two independent reviewers performed 10% of the study selection and data extraction. Data collected underwent descriptive statistics.ResultsOf the 4343 references identified, 31 were included in the scoping review. About 360 indicators were identified and preliminary screened by two stroke experts. Fifty-four indicators were evaluated for validity, relevance and feasibility by a committee of experts including a partner patient using a Delphi method. A total of 34 indicators were selected and classified based on dimensions of care performance such as accessibility of services, quality of care and resource optimisation. Safety accounted for about one-third of the indicators, while there were few indicators for sustainability, equity of access and responsiveness.ConclusionThis scoping review shows there are many clinical and organisational indicators in the literature that are relevant, valid and feasible for improving the quality of care in the acute phase of ischaemic stroke. Future research is essential to highlight clinical and organisational practices in the acute phase.Registration detailshttps://osf.io/qc4mk/

show abstract

Section: Resultsmentioning

confidence: 99%

Clinical and organisational quality indicators for the optimal management of acute ischaemic stroke in the era of thrombectomy: a scoping review and expert consensus study

Bélanger,

Beaudet,

Lapointe

et al. 2024

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Recent surveys show that their incidence rate is increasing year by year and patients are getting younger and younger, which has become one of the main causes of human death [3,4] . Cerebral infarction is an ischemic stroke, accounting for 70 % of all acute cerebrovascular diseases in incidence rate [5,6] . Clinical treatment of cerebrovascular diseases usually involves controlling the condition through thrombolysis, anticoagulation and repair of damaged nerves, but there is still a lack of specific drugs and related treatment plans.…”

mentioning

confidence: 99%

Analysis of the Effects of Betahistine Hydrochloride Combined with Atorvastatin on Procalcitonin and C-Reactive Protein Levels in Acute Cerebrovascular Disease

Sun,

Pan,

Wang

et al. 2023

IJPS

View full text Add to dashboard Cite

Effects of Betahistine Hydrochloride Combined with Atorvastatin in Acute Cerebrovascular DiseaseAcute cerebrovascular diseases are a group of common clinical diseases characterized by abnormal cerebrovascular circulation. Among many common and frequently occurring diseases admitted to emergency and critical care departments, the mortality rate is high and the disability rate of surviving patients is also high. In addition to central injury in acute cerebrovascular diseases, which can lead to poor prognosis in patients, fluctuations in the properties and functions of local and circulating immune mediators can also trigger the body to enter an immune imbalance state, leading to poor prognosis in some patients after receiving systematic symptomatic support treatment. Betahistine hydrochloride is a histamine H 1 receptor agonist that can resist platelet aggregation. The drug has a half-life of 5 h through liver metabolism and will not remain in the body, resulting in high safety. In addition, betahistine hydrochloride also has a diuretic effect, which can promote blood circulation, increase organ blood perfusion, reduce myocardial oxygen consumption, improve patient blood pressure levels and ultimately improve symptoms of cardiovascular and cerebrovascular ischemia and hypoxia. Therefore, this article mainly reviews the treatment of acute cerebrovascular disease with betahistine hydrochloride combined with atorvastatin, providing scientific reference for clinical treatment of acute cerebrovascular disease.

show abstract

Attention to acute cerebrovascular disease in Guipúzcoa: description of the results of a reference hospital in a centralized care model

Cited by 2 publications

References 17 publications

Clinical and organisational quality indicators for the optimal management of acute ischaemic stroke in the era of thrombectomy: a scoping review and expert consensus study

Clinical and organisational quality indicators for the optimal management of acute ischaemic stroke in the era of thrombectomy: a scoping review and expert consensus study

Analysis of the Effects of Betahistine Hydrochloride Combined with Atorvastatin on Procalcitonin and C-Reactive Protein Levels in Acute Cerebrovascular Disease

Contact Info

Product

Resources

About